Efficacy and safety of basal‐first titration order in individuals with type 2 diabetes receiving short‐term intensive insulin therapy: An exploratory analysis of BEYOND V
Diabetes, Obesity and Metabolism · 2023
DOI: 10.1111/dom.14970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Yijun Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: The First Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemia. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi, China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To present the results of an exploratory analysis of the BEYOND V study in which Chinese individuals with uncontrolled type 2 diabetes (T2D) received short‐term intensive insulin therapy (SIIT) during study run‐in (prior to randomization) using a basal‐first insulin titration method. Materials and methods This was exclusively an exploratory analysis of the 7‐ to 10‐day run‐in period of BEYOND V. Participants were hospitalized and had oral therapies withdrawn (except metformin). They received SIIT with once‐daily insulin glargine and three‐times‐daily premeal insulin glulisine, titrated daily from a total starting dose of 0.4 to 0.5 units/kg/d, first adjusting insulin glargine to achieve fasting blood glucose (FBG) of 4.4 to 6.1 mmol/L (79 to 119 mg/dL), then insulin glulisine to achieve pre‐meal blood glucose of 4.4 to 6.1 mmol/L. Key outcomes were the proportions of participants achieving FBG and 2‐hour postprandial blood glucose (PBG) targets.
Results
Overall, 397 entered the run‐in (mean 54.2 years, 235 males [59.2%]). At the end of SIIT, 374/396 participants (94.4%) had both FBG
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Medical Center of Chinese PLA General Hospital, Beijing, China.
- Beijing Hospital, National Center of Gerontology, Beijing, China.
- Panjin Central Hospital, Panjin, China.
- Second Hospital of Shijiazhuang, Shijiazhuang, China.
- Harbin the First Hospital, Harbin, China.
- Second Affiliated Hospital of Baotou Medical College, Baotou, China.
ORCID-Profile: Lixin Guo, Yiming Mu, Jingcheng Liu
Förderung
- Sanofi, China
Zitieren
APA
Li, Y., Yu, D., Guo, L., Mu, Y., Wan, H., Wang, J., Xu, B., Wang, G., Jiang, C., Liang, L., Zhang, J., Liu, J., Zhang, M., & Cui, N. (2023). Efficacy and safety of basal‐first titration order in individuals with type 2 diabetes receiving short‐term intensive insulin therapy: An exploratory analysis of BEYOND V. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.14970
Vancouver
Li Y, Yu D, Guo L, Mu Y, Wan H, Wang J, et al. Efficacy and safety of basal‐first titration order in individuals with type 2 diabetes receiving short‐term intensive insulin therapy: An exploratory analysis of BEYOND V. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.14970
BibTeX
@article{Li2023,
author = {Li, Yijun and Yu, Dongni and Guo, Lixin and Mu, Yiming and Wan, Hailong and Wang, Junfen and Xu, Binhua and Wang, Guoping and Jiang, Chengxia and Liang, Li and Zhang, Jiewen and Liu, Jingcheng and Zhang, Minlu and Cui, Nan},
title = {Efficacy and safety of basal‐first titration order in individuals with type 2 diabetes receiving short‐term intensive insulin therapy: An exploratory analysis of BEYOND V},
journal = {Diabetes, Obesity and Metabolism},
year = {2023},
doi = {10.1111/dom.14970}
}
EUVIMED